YAL064W Antibody

What is YAL064W-B and what cellular functions is it associated with?

YAL064W-B is an uncharacterized membrane protein in Saccharomyces cerevisiae (baker's yeast) with a multi-pass membrane protein structure. While its precise function remains to be fully elucidated, research has investigated its potential role in oxidative stress response pathways and terpenoid biosynthesis. In studies examining β-caryophyllene production, YAL064W-B was analyzed alongside other genetic elements, though mutations in the YAL064W-B/TDA8 intergenic region did not significantly impact growth kinetics or β-caryophyllene production when compared to control strains . The protein is documented in several databases including KEGG (sce:YAL064W-B) and STRING (4932.YAL064W-B), with its sequence information available through UniProt (O13512).

What are the optimal storage conditions for YAL064W-B antibodies to maintain activity?

YAL064W-B antibodies are typically supplied in a buffer containing preservatives (0.03% Proclin 300) and stabilizers (50% Glycerol in 0.01M Phosphate Buffered Saline, pH 7.4). For maintaining optimal activity, these antibodies should be stored at -20°C for long-term storage, while avoiding repeated freeze-thaw cycles that can compromise binding capacity. When working with the antibody, aliquoting into single-use volumes is recommended to prevent degradation. For short-term use (1-2 weeks), storage at 4°C is acceptable, but antibody activity should be verified through appropriate controls if stored for extended periods at this temperature.

What detection methods work best with YAL064W-B antibodies in yeast research?

For YAL064W-B detection in yeast cells, multiple methods can be employed depending on the experimental question. Western blotting remains the gold standard for protein quantification, requiring appropriate membrane protein extraction techniques such as detergent-based lysis (e.g., with RIPA buffer containing 1% NP-40 or Triton X-100). For localization studies, immunofluorescence microscopy works effectively when cells are fixed with formaldehyde and permeabilized with enzymes like zymolyase to ensure antibody access to membrane proteins. Flow cytometry can be utilized for quantitative analysis across populations when studying expression patterns in different yeast strains or under varying conditions. When designing experiments, researchers should include appropriate controls including non-specific antibody controls and, when possible, YAL064W-B deletion mutants as demonstrated in genetic studies .

How should I optimize immunoprecipitation protocols for YAL064W-B as a membrane protein?

Immunoprecipitation (IP) of YAL064W-B requires specialized protocols due to its nature as a multi-pass membrane protein. Begin with an effective membrane protein solubilization method using a two-step extraction: first lyse cells using mechanical disruption (e.g., glass bead vortexing for yeast) in a buffer containing protease inhibitors, then solubilize membrane proteins with a detergent mixture (1-2% digitonin, 0.5% DDM, or 1% Triton X-100). Cross-linking with DSP (dithiobis(succinimidyl propionate)) prior to lysis can help preserve protein-protein interactions.

For the IP itself, pre-clear lysates with protein A/G beads for 1 hour at 4°C, then incubate with YAL064W-B antibody (5-10 μg per 1 mg of total protein) overnight at 4°C with gentle rotation. Capture antibody-protein complexes using fresh protein A/G beads for 2-3 hours, followed by at least 5 washes with decreasing detergent concentrations. Elute proteins by boiling in SDS-PAGE sample buffer containing DTT to break any crosslinks.

When validating IP results, appropriate controls are crucial, including:

• IgG isotype control to assess non-specific binding

• Input sample (pre-IP lysate) to confirm target presence

• Unbound fraction to verify depletion

• IP from YAL064W-B deletion strains as a specificity control

What are the recommended protocols for analyzing YAL064W-B expression changes in yeast during oxidative stress?

To effectively analyze YAL064W-B expression during oxidative stress, a multi-method approach is recommended based on established experimental designs used in related research :

• Stress induction protocol: Expose cells to H₂O₂ in a controlled manner, such as using 50-200 mM H₂O₂ for 30 minutes as demonstrated in oxidative stress tolerance studies . Include multiple timepoints (e.g., 15, 30, 60, 120 minutes) to capture expression dynamics.

• mRNA quantification: Extract total RNA using hot phenol extraction optimized for yeast, followed by RT-qPCR with primers specific to YAL064W-B. Normalize expression against multiple reference genes (ACT1, TDH3, and ALG9) that maintain stability under oxidative stress.

• Protein analysis: Perform Western blotting using YAL064W-B antibody on membrane-enriched fractions. For accurate quantification, use densitometry normalized to a membrane protein loading control such as Pma1p.

• Correlative analyses: Compare expression patterns of YAL064W-B with other genes known to be involved in oxidative stress response (e.g., CTT1, YAP1-regulated genes) to identify potential co-regulation.

• Single-cell analysis: To account for cell-to-cell variability, combine the YAL064W-B antibody with flow cytometry after cell permeabilization, using appropriate gating strategies to separate populations based on expression levels and oxidative damage markers.

When interpreting results, consider that proteins like YAL064W-B may respond differently to acute versus chronic oxidative stress, as suggested by the differential responses observed in periodic versus continuous H₂O₂ challenge experiments .

How can I effectively use YAL064W-B antibodies in co-localization studies with other membrane proteins?

For effective co-localization studies combining YAL064W-B with other membrane proteins, implement the following methodological approach:

• Sample preparation: Fix yeast cells with 4% paraformaldehyde for 30 minutes, followed by spheroplasting with zymolyase (100T, 10 μg/ml) for 20-30 minutes to improve antibody penetration while preserving membrane architecture.

• Blocking and permeabilization: Use a buffer containing 1% BSA, 0.1% saponin, and 0.1% Triton X-100 in PBS for 1 hour to reduce non-specific binding while maintaining membrane protein epitope accessibility.

• Sequential antibody application: Apply primary antibodies sequentially rather than simultaneously, starting with the YAL064W-B antibody followed by antibodies against other target proteins. This approach minimizes potential cross-reactivity, particularly important when antibodies are derived from the same species.

• Fluorophore selection: Choose fluorophores with minimal spectral overlap (e.g., Alexa 488 for YAL064W-B and Alexa 647 for the second protein) and include single-label controls to assess bleed-through.

• Imaging considerations: Use confocal microscopy with appropriate z-stack sampling (0.2-0.3 μm steps) to capture the complete three-dimensional distribution of membrane proteins. Employ deconvolution algorithms to enhance signal resolution.

• Quantitative co-localization: Calculate Pearson's and Manders' coefficients to quantify the degree of co-localization, with values across multiple cells (n>30) to account for cellular heterogeneity.

• Validation controls: Include subcellular markers for specific membrane compartments (ER, Golgi, plasma membrane) to confirm the membrane localization pattern observed with YAL064W-B antibody.

This methodology has been adapted from approaches used in studying other yeast membrane proteins and their interactions within cellular stress response pathways .

How can YAL064W-B antibodies be utilized to investigate potential roles in terpene biosynthesis pathways?

Given the context of YAL064W-B being studied alongside terpene biosynthesis genes in adaptive laboratory evolution experiments , researchers can leverage YAL064W-B antibodies to investigate potential functional relationships through several advanced approaches:

• Proximity-dependent biotinylation (BioID): Fuse YAL064W-B with a promiscuous biotin ligase (BirA*), express in yeast, and use antibodies to verify expression and localization. After biotin exposure, identify proximal proteins via streptavidin pulldown and mass spectrometry, focusing on known terpene pathway components.

• Co-immunoprecipitation with pathway components: Use YAL064W-B antibodies for pull-down experiments followed by probing for known terpene biosynthesis proteins (e.g., terpene synthases, prenyl transferases). This approach can reveal direct protein-protein interactions that may suggest functional relationships.

• Antibody-based inhibition studies: In permeable spheroplast systems, introduce YAL064W-B antibodies and measure effects on terpene production rates using GC-MS quantification of products like β-caryophyllene, similar to the quantification methods described in the adaptive laboratory evolution study .

• Protein complex isolation: Employ blue native PAGE combined with YAL064W-B antibody detection in Western blots to identify native membrane protein complexes containing YAL064W-B and potential terpene biosynthesis or transport components.

• Correlative expression analysis: Use YAL064W-B antibodies alongside antibodies against terpene pathway enzymes to quantify relative expression levels across different growth conditions or in evolved strains showing enhanced terpene production, such as the β-caryophyllene hyperproducers identified through adaptive evolution .

When interpreting results, consider that YAL064W-B, as a membrane protein, might function in compartmentalization, transport, or localization of terpene pathway components rather than in direct catalytic steps of biosynthesis.

What approaches can resolve contradictory data when YAL064W-B antibody staining patterns differ from GFP-fusion localization results?

When faced with discrepancies between antibody-based localization and GFP-fusion protein results for YAL064W-B, a systematic troubleshooting approach should be implemented:

• Epitope accessibility analysis: YAL064W-B, as a multi-pass membrane protein, may have epitopes that become inaccessible in certain conformational states or membrane environments. Perform epitope mapping using a panel of antibodies targeting different regions of the protein and compare their staining patterns.

• Fixation comparison study: Test multiple fixation methods (paraformaldehyde, methanol, glutaraldehyde) and concentrations to determine if protein conformation or epitope exposure is affected differently by each method.

• Detergent optimization: Conduct a titration of different membrane-permeabilizing detergents (Triton X-100, saponin, digitonin) at various concentrations to identify conditions that maintain epitope integrity while allowing antibody access.

• Live cell imaging validation: For GFP-fusion constructs, confirm functionality by complementation testing in YAL064W-B deletion strains, and assess whether the fusion affects protein dynamics using FRAP (Fluorescence Recovery After Photobleaching).

• Expression level effects: Compare antibody staining patterns across a range of expression levels (native, overexpressed, underexpressed) to determine if localization discrepancies are concentration-dependent, which could indicate saturation of trafficking machinery.

• Correlative Light and Electron Microscopy (CLEM): Combine immunogold labeling with YAL064W-B antibodies for electron microscopy visualization alongside fluorescence microscopy of GFP-tagged protein to resolve subcellular localization at higher resolution.

• Conditional expression analysis: Examine localization patterns under different physiological conditions (oxidative stress, carbon source variation) using both methods, as certain conditions may trigger relocalization or conformational changes that affect detection differently between methods.

The methodological approach should include appropriate controls at each step, including wild-type cells (negative control) and cells with confirmed YAL064W-B overexpression (positive control) to calibrate detection thresholds .

How can I design experiments to clarify whether YAL064W-B mutations affect β-caryophyllene production through direct or indirect mechanisms?

The adaptive laboratory evolution study identified mutations in several genes, including the YAL064W-B/TDA8 intergenic region, though this specific mutation did not significantly impact β-caryophyllene production . To design experiments that could clarify potential direct or indirect mechanisms of YAL064W-B in terpene metabolism, implement the following experimental design:

• Controlled expression system analysis:

  • Create a series of strains with YAL064W-B under inducible promoters of varying strengths

  • Quantify β-caryophyllene production using GC-MS at each expression level

  • Plot correlation between YAL064W-B protein levels (determined via antibody-based Western blot) and terpene production

• Temporal expression and product formation study:

  • Use time-course sampling to correlate YAL064W-B expression dynamics (via antibody detection) with β-caryophyllene accumulation

  • Implement metabolic flux analysis with 13C-labeled precursors to track carbon flow through the pathway

  • Calculate time delays between YAL064W-B expression changes and metabolite level changes

• Protein-metabolite interaction analysis:

  • Perform cellular thermal shift assays (CETSA) with YAL064W-B antibodies in the presence/absence of pathway intermediates

  • Use microscale thermophoresis to detect potential direct binding between purified YAL064W-B and terpene precursors or products

  • Implement crosslinking mass spectrometry to identify metabolites that may associate with YAL064W-B

• Subcellular compartmentalization investigation:

  • Use YAL064W-B antibodies in combination with organelle markers to track protein localization relative to sites of terpene synthesis

  • Isolate membrane fractions and quantify both protein (via antibody detection) and terpene content (via GC-MS)

  • Perform electron microscopy with immunogold labeling to visualize spatial relationships at high resolution

• Comparative analysis with known effector mutations:

  • Generate strains combining YAL064W-B modifications with the beneficial mutations identified in the study (STE6 T1025N and MST27/tR(UCU)G1 int)

  • Use antibodies against all target proteins to monitor expression levels

  • Quantify epistatic effects by comparing β-caryophyllene production in single and combined mutants

Results from these approaches should be analyzed using multivariate statistics to differentiate between direct effects (strong immediate correlations) and indirect effects (delayed or network-dependent correlations).

What are the most effective methods for validating YAL064W-B antibody specificity in yeast systems?

Validating antibody specificity is crucial for reliable results, particularly for relatively uncharacterized proteins like YAL064W-B. Implement these methodological approaches for comprehensive validation:

• Genetic controls: The gold standard validation approach employs:

  • Wild-type yeast strains (positive control)

  • YAL064W-B deletion strains (negative control)

  • YAL064W-B overexpression strains (enhanced signal control)

  Compare antibody signal across these strains using Western blotting and immunofluorescence to confirm signal specificity, as demonstrated in genetic studies of related proteins .

• Epitope competition assay: Pre-incubate the YAL064W-B antibody with excess purified peptide corresponding to the immunogen. If the antibody is specific, this should significantly reduce or eliminate signal in subsequent detection assays.

• Multiple antibody validation: If available, use antibodies generated against different epitopes of YAL064W-B and compare their staining patterns. Concordant results increase confidence in specificity.

• Immunoprecipitation-Mass Spectrometry: Perform IP with the YAL064W-B antibody followed by mass spectrometry identification of pulled-down proteins. The predominant protein identified should be YAL064W-B.

• Inducible expression system: Create a system where YAL064W-B expression can be turned on/off (e.g., GAL1 promoter in yeast) and verify that antibody signal correlates with expression status.

• Western blot analysis: Beyond presence/absence, verify that the detected protein has the expected molecular weight (~17 kDa for YAL064W-B). For membrane proteins, sample preparation should include complete denaturation to prevent aggregation that might affect migration.

• Cross-reactivity assessment: Test the antibody against related yeast proteins or in closely related yeast species with varying levels of YAL064W-B homology to assess potential cross-reactivity.

• Signal-to-noise optimization: Determine optimal antibody dilutions (typically starting with 1:500, 1:1000, and 1:2000) and incubation conditions that maximize specific signal while minimizing background.

How should I address inconsistent YAL064W-B antibody signals in Western blots of membrane protein fractions?

Inconsistent Western blot signals when working with membrane proteins like YAL064W-B often stem from sample preparation and experimental variables. Implement this systematic troubleshooting protocol:

• Optimized membrane protein extraction:

  • Compare multiple extraction methods: (a) Detergent-based: 1% DDM, 1% Triton X-100, or RIPA buffer; (b) Mechanical: Glass bead disruption followed by differential centrifugation; (c) Commercial membrane protein extraction kits

  • Maintain all buffers at 4°C and include protease inhibitor cocktails with EDTA

  • For YAL064W-B specifically, include reducing agents like 5 mM DTT to prevent oxidation of membrane proteins

• Sample preparation refinements:

  • Avoid boiling samples (use 37°C for 30 minutes instead) to prevent membrane protein aggregation

  • Include 8M urea or 6M guanidine HCl in loading buffer to ensure complete denaturation

  • Use fresh samples whenever possible; if storage is necessary, maintain at -80°C with 10% glycerol as cryoprotectant

• Electrophoresis optimization:

  • Use gradient gels (4-15% or 4-20%) for better resolution of membrane proteins

  • Add 0.1% SDS to running buffer to maintain protein denaturation during separation

  • Run gels at lower voltage (80-100V) to prevent sample heating and protein aggregation

• Transfer parameters:

  • Implement wet transfer systems for membrane proteins

  • Use PVDF membranes (0.2 μm pore size) pre-activated with methanol

  • Include 0.1% SDS in transfer buffer to promote protein solubility

  • Extend transfer time (overnight at 30V, 4°C) for complete transfer of hydrophobic proteins

• Signal detection enhancements:

  • Employ signal enhancement systems (e.g., biotin-streptavidin amplification)

  • Use high-sensitivity ECL substrates for chemiluminescence detection

  • Consider fluorescent secondary antibodies for more stable and quantifiable signals

• Quantitative controls:

  • Include calibration curve using purified recombinant protein if available

  • Use consistent loading controls appropriate for membrane fractions (e.g., Na+/K+ ATPase)

  • Implement technical replicates (minimum n=3) to establish statistical significance

• Antibody optimization protocol:

  • Test multiple antibody concentrations in a dot-blot format to determine optimal dilution

  • Extend primary antibody incubation time (overnight at 4°C with gentle rocking)

  • Compare different blocking agents (5% BSA often works better than milk for membrane proteins)

This systematic approach addresses the key variables affecting membrane protein Western blotting consistency and should substantially improve reproducibility when working with YAL064W-B antibodies.

What factors should be considered when comparing results from different batches of YAL064W-B antibodies?

When comparing results from different antibody batches, researchers should implement a comprehensive validation protocol to ensure data comparability and reliability:

• Batch standardization assessment:

  • Perform side-by-side testing on identical samples using both antibody batches

  • Calculate signal intensity ratios between batches using densitometry

  • Develop batch correction factors if consistent ratio differences are observed

  • Document lot numbers and manufacturing dates for all experiments

• Epitope verification:

  • Request epitope information from manufacturers to confirm targeting of identical protein regions

  • For polyclonal antibodies, recognize that epitope representation may vary between batches

  • For custom antibodies, verify immunogen sequence identity between production runs

• Sensitivity comparison:

  • Generate standard curves using purified target protein or overexpression lysates

  • Determine detection limits for each batch

  • Calculate EC50 values to quantify affinity differences

  • Adjust working concentrations based on relative sensitivity

• Cross-reactivity profiling:

  • Test both batches against YAL064W-B deletion strains to assess non-specific binding

  • Perform immunoprecipitation followed by mass spectrometry to identify all proteins pulled down by each batch

  • Compare off-target binding profiles between batches

• Application-specific validation:

  • For immunofluorescence: Compare subcellular localization patterns and signal-to-noise ratios

  • For Western blotting: Assess band pattern consistency and intensity at equivalent dilutions

  • For flow cytometry: Compare population distribution patterns and median fluorescence intensities

• Storage and handling standardization:

  • Maintain identical storage conditions (temperature, aliquot volume)

  • Standardize freeze-thaw cycles

  • Use the same diluents and stabilizers

  • Record time in storage for each batch

• Documentation requirements:

  • Maintain validation datasets for each antibody batch

  • Include batch information in methods sections of publications

  • Consider including batch comparison data in supplementary materials for critical experiments

• Statistical approach for multi-batch datasets:

  • Include batch as a factor in statistical models

  • Consider using mixed-effects models when combining data from multiple batches

  • Implement batch correction algorithms when appropriate

How should researchers interpret YAL064W-B protein expression data in the context of genetic mutation studies?

When interpreting YAL064W-B protein expression data in genetic mutation studies, researchers should implement a structured analytical framework that considers multiple levels of biological context:

• Baseline expression characterization:

  • Establish normal expression ranges in wild-type strains under standard conditions

  • Analyze expression variability across cell cycle phases and growth stages

  • Document subcellular localization patterns using quantitative imaging metrics

  • Create reference datasets for comparison with mutant strains

• Mutation impact analysis framework:

  • Distinguish between mutations in the YAL064W-B coding region versus regulatory regions

  • For intergenic mutations (such as YAL064W-B/TDA8 int) , analyze potential effects on promoter activity or regulatory element function

  • Consider proximity to known transcription factor binding sites when interpreting expression changes

  • Evaluate mRNA stability changes that might affect protein levels independent of transcription

• Multi-level data integration:

  • Correlate protein expression with mRNA levels to identify post-transcriptional regulation

  • Analyze protein stability and turnover rates in different genetic backgrounds

  • Consider post-translational modifications that might affect antibody recognition

  • Cross-reference with phenotypic data, such as growth rates and stress tolerance measurements as shown in the adaptive laboratory evolution study

• Statistical interpretation guidelines:

  • Implement appropriate statistical tests for expression differences (t-tests for pairwise comparisons, ANOVA for multiple conditions)

  • Calculate effect sizes (Cohen's d) to quantify the magnitude of expression changes

  • Establish significance thresholds that account for multiple comparisons

  • Present both raw and normalized data to provide complete context

• Network-based interpretation:

  • Place YAL064W-B expression changes within the context of known interaction networks

  • Perform gene set enrichment analysis to identify coordinated expression changes

  • Consider pathway-level impacts rather than focusing solely on individual gene effects

  • Evaluate potential compensatory mechanisms in the membrane proteome

• Experimental design considerations for interpretation:

  • Account for technical variables such as antibody batch effects

  • Consider biological variables like strain background differences

  • Interpret acute versus chronic effects separately

  • Recognize that expression changes may be adaptive responses rather than direct mutation effects

This framework enables researchers to develop more comprehensive interpretations of YAL064W-B expression data, particularly when comparing results across different genetic backgrounds or experimental conditions as seen in β-caryophyllene production studies .

What computational approaches can enhance the analysis of co-immunoprecipitation data obtained using YAL064W-B antibodies?

Advanced computational approaches can significantly enhance the analysis of co-immunoprecipitation (co-IP) data for membrane proteins like YAL064W-B. Implement the following computational workflow:

• Proteomics data preprocessing:

  • Apply retention time alignment algorithms to account for chromatographic drift

  • Implement MS1-based label-free quantification with appropriate normalization

  • Filter protein identifications using target-decoy approach (1% FDR threshold)

  • Apply specialized membrane protein identification algorithms that account for hydrophobic peptides and modified residues

• Interaction specificity scoring:

  • Calculate Significance Analysis of INTeractome (SAINT) scores to distinguish true interactors from background

  • Implement CompPASS (Comparative Proteomics Analysis Software Suite) to identify high-confidence interacting proteins

  • Develop custom specificity scores incorporating:

    • Enrichment ratio relative to control IPs

    • Reproducibility across biological replicates

    • Known contaminant filtering using CRAPome database

• Network analysis enhancements:

  • Construct protein interaction networks using weighted edges based on quantitative values

  • Apply Markov Clustering Algorithm (MCL) to identify protein complexes

  • Use Random Walk with Restart (RWR) algorithms to predict functional associations

  • Implement diffusion-based methods to detect indirect interactions

• Integration with orthogonal datasets:

  • Cross-reference with publicly available yeast two-hybrid data

  • Incorporate membrane protein topology predictions to evaluate physical plausibility of interactions

  • Integrate with transcriptomic data to identify co-regulated interaction partners

  • Correlate with phenotypic data from mutation studies, such as the β-caryophyllene production phenotypes

• Visualization and interpretation tools:

  • Develop interactive network visualizations with subcellular localization overlays

  • Implement hierarchical clustering with heat maps to identify interaction patterns

  • Create pathway enrichment visualizations to contextualize interactions

  • Design protein domain interaction maps to highlight specific binding regions

• Machine learning approaches:

  • Train random forest models to classify high-confidence interactions

  • Implement deep learning to predict interaction potential based on protein features

  • Use semi-supervised learning to propagate interaction confidence through networks

  • Develop ensemble methods combining multiple predictors for improved accuracy

• Reproducibility and transparency enhancements:

  • Provide computational notebooks documenting analysis workflows

  • Implement containerized analysis environments for reproducibility

  • Establish clear versioning of analysis code and reference databases

  • Make raw data and processed results available through appropriate repositories

This computational framework provides researchers with robust tools to extract meaningful interaction data from co-IP experiments using YAL064W-B antibodies, enabling more comprehensive understanding of this membrane protein's functional context and potential roles in cellular processes such as terpene metabolism .

How can researchers harness YAL064W-B antibodies to investigate potential roles in intracellular trafficking of terpenoid compounds?

Building on findings that connect membrane proteins to terpenoid metabolism , researchers can implement the following integrated experimental approach to investigate YAL064W-B's potential role in terpenoid trafficking:

• Spatial co-localization mapping:

  • Perform triple-labeling experiments using YAL064W-B antibodies, fluorescent terpenoid analogs, and organelle markers

  • Implement super-resolution microscopy (STED or STORM) to resolve membrane microdomains

  • Calculate spatial correlation indices between YAL064W-B localization and terpenoid accumulation sites

  • Develop time-lapse imaging to track dynamic relationships during biosynthesis

• Membrane microdomain isolation:

  • Fractionate yeast membranes using density gradient ultracentrifugation

  • Identify lipid raft and non-raft fractions using established markers

  • Quantify YAL064W-B distribution using antibody-based detection

  • Correlate with terpenoid distribution measured by targeted metabolomics

  • Compare patterns in wild-type and β-caryophyllene hyperproducer strains

• Protein-metabolite interaction analysis:

  • Develop antibody-based pull-down assays optimized for hydrophobic interactions

  • Implement metabolite profiling of immunoprecipitated complexes

  • Use photoaffinity labeling with terpenoid analogs followed by antibody detection

  • Perform limited proteolysis in the presence/absence of terpenoids to identify conformational changes

• Transport assays in reconstituted systems:

  • Create proteoliposomes containing purified YAL064W-B

  • Measure terpenoid transport using fluorescence-based assays

  • Compare transport kinetics with positive controls (known transporters like STE6 )

  • Assess the impact of the STE6 T1025N mutation identified in β-caryophyllene hyperproducers

• Genetic interaction mapping:

  • Generate double mutants combining YAL064W-B modifications with mutations in known terpenoid transporters

  • Use antibodies to confirm expression levels in combination strains

  • Quantify epistatic effects on terpenoid production and localization

  • Implement synthetic genetic array analysis to identify broader functional connections

• Computational modeling integration:

  • Develop molecular dynamics simulations of YAL064W-B in membranes

  • Dock terpenoid structures to identify potential binding sites

  • Predict conformational changes associated with transport function

  • Generate testable hypotheses about functional residues for site-directed mutagenesis

• Specialized mass spectrometry approaches:

  • Implement DESI-MS (Desorption Electrospray Ionization Mass Spectrometry) imaging to visualize spatial distribution of terpenoids in relation to YAL064W-B

  • Use antibody-based proximity labeling (APEX or BioID) coupled with MS to identify proteins in physical proximity to YAL064W-B

  • Perform crosslinking MS to capture transient protein-metabolite interactions

This methodological framework provides researchers with multiple complementary approaches to investigate YAL064W-B's potential role in terpenoid trafficking, building upon the connection between membrane proteins and terpene production established in adaptive laboratory evolution studies .

What experimental designs can effectively assess YAL064W-B function in the context of oxidative stress response pathways?

To systematically investigate YAL064W-B's potential role in oxidative stress response pathways, as suggested by its inclusion in oxidative stress tolerance studies , researchers should implement this comprehensive experimental framework:

• Temporal expression profiling:

  • Subject yeast cultures to precisely controlled oxidative challenge (50-200 mM H₂O₂) as used in previous studies

  • Collect samples across multiple timepoints (0, 15, 30, 60, 120, 240 minutes)

  • Quantify YAL064W-B protein levels using antibody-based Western blotting

  • Correlate with expression patterns of known oxidative stress responders (e.g., CTT1, SOD1, TRX2)

  • Compare responses in wild-type and oxidative stress-sensitive strains

• Subcellular relocalization analysis:

  • Perform immunofluorescence using YAL064W-B antibodies before and after oxidative challenge

  • Implement live-cell imaging with GFP-tagged YAL064W-B to track dynamic responses

  • Quantify changes in membrane distribution pattern using computational image analysis

  • Correlate relocalization with markers of membrane damage or reorganization

• Interactome dynamics assessment:

  • Conduct time-resolved co-immunoprecipitations with YAL064W-B antibodies during stress response

  • Identify stress-specific interaction partners using mass spectrometry

  • Implement APEX2 proximity labeling to capture transient interactions during stress

  • Construct dynamic interaction networks showing temporal changes

• Functional studies using deletion and overexpression:

  • Generate YAL064W-B deletion strains and measure oxidative stress tolerance

  • Create controlled overexpression systems with varied YAL064W-B levels

  • Subject strains to H₂O₂ challenge protocol as established in previous research

  • Quantify survival rates, growth recovery, and ROS accumulation

• Post-translational modification analysis:

  • Immunoprecipitate YAL064W-B using specific antibodies before and after oxidative stress

  • Perform MS/MS analysis to identify stress-induced modifications

  • Focus on oxidation-sensitive residues (Cys, Met) and regulatory modifications (phosphorylation)

  • Validate using modification-specific antibodies if available

• Membrane integrity and composition studies:

  • Assess membrane permeability in wild-type versus YAL064W-B mutant strains under oxidative stress

  • Measure lipid peroxidation levels in different genetic backgrounds

  • Analyze membrane lipid composition changes in response to stress

  • Correlate with YAL064W-B localization and abundance

• Multi-stress comparative analysis:

  • Compare YAL064W-B response across different stressors (oxidative, osmotic, heat shock)

  • Identify stress-specific versus general response patterns

  • Implement RNA-seq and proteomics to place YAL064W-B in broader stress response networks

  • Assess the correlation between YAL064W-B expression and terpene production under different stress conditions

• Genetic interaction mapping during stress:

  • Perform synthetic genetic array analysis under oxidative stress conditions

  • Identify genetic interactions that are stress-specific

  • Focus on interactions with known oxidative stress response genes

  • Validate key interactions with targeted double mutant analysis

This experimental design framework provides a systematic approach to investigating YAL064W-B's potential role in oxidative stress response, building upon the connection between membrane proteins and stress tolerance established in adaptive laboratory evolution studies .